Canada markets closed

Prelude Therapeutics Incorporated (PRLD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.9900+0.2600 (+6.97%)
At close: 04:00PM EDT
3.9900 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 202.66M
Enterprise Value -13.39M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.85
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.10

Trading Information

Stock Price History

Beta (5Y Monthly) 1.50
52-Week Change 3-38.85%
S&P500 52-Week Change 323.57%
52 Week High 36.8900
52 Week Low 31.6600
50-Day Moving Average 34.4156
200-Day Moving Average 33.6111

Share Statistics

Avg Vol (3 month) 367.81k
Avg Vol (10 day) 349.77k
Shares Outstanding 542.07M
Implied Shares Outstanding 654.92M
Float 813.63M
% Held by Insiders 19.04%
% Held by Institutions 196.32%
Shares Short (Apr 15, 2024) 4604.04k
Short Ratio (Apr 15, 2024) 414.72
Short % of Float (Apr 15, 2024) 44.54%
Short % of Shares Outstanding (Apr 15, 2024) 41.10%
Shares Short (prior month Mar 15, 2024) 4643.17k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-33.19%
Return on Equity (ttm)-56.33%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -131.11M
Net Income Avi to Common (ttm)-121.83M
Diluted EPS (ttm)-2.0200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)232.94M
Total Cash Per Share (mrq)4.24
Total Debt (mrq)16.89M
Total Debt/Equity (mrq)7.12%
Current Ratio (mrq)10.79
Book Value Per Share (mrq)4.32

Cash Flow Statement

Operating Cash Flow (ttm)-107.06M
Levered Free Cash Flow (ttm)-58.93M